Market Moves
Korea's Ybrain electroceutical startup restarts its stalled KOSDAQ IPO
Korean depression-tDCS device maker Ybrain has restarted its KOSDAQ IPO process in 2026, with Ceragem holding a 41.19 percent stake and NH Investment & Securities as lead bookrunner. Listing is targeted for early 2027.